302 related articles for article (PubMed ID: 31292670)
21. Role of Human N-Acetyltransferase 2 Genetic Polymorphism on Aromatic Amine Carcinogen-Induced DNA Damage and Mutagenicity in a Chinese Hamster Ovary Cell Mutation Assay.
Baldauf KJ; Salazar-González RA; Doll MA; Pierce WM; States JC; Hein DW
Environ Mol Mutagen; 2020 Feb; 61(2):235-245. PubMed ID: 31490564
[TBL] [Abstract][Full Text] [Related]
22. Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.
Hein DW; Doll MA
Arch Toxicol; 2017 Aug; 91(8):2827-2835. PubMed ID: 28523442
[TBL] [Abstract][Full Text] [Related]
23. Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N- and O-acetylation of arylamine carcinogens.
Hein DW; Doll MA; Rustan TD; Gray K; Ferguson RJ; Feng Y
Toxicol Appl Pharmacol; 1994 Jan; 124(1):16-24. PubMed ID: 8291057
[TBL] [Abstract][Full Text] [Related]
24. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.
Gu J; Liang D; Wang Y; Lu C; Wu X
Mutat Res; 2005 Mar; 581(1-2):97-104. PubMed ID: 15725609
[TBL] [Abstract][Full Text] [Related]
25. Induction of glucose production by heterocyclic amines is dependent on N-acetyltransferase 2 genetic polymorphism in cryopreserved human hepatocytes.
Walls KM; Hong KU; Hein DW
Toxicol Lett; 2023 Jul; 383():192-195. PubMed ID: 37423373
[TBL] [Abstract][Full Text] [Related]
26. Metabolic activation of heterocyclic aromatic amines catalyzed by human arylamine N-acetyltransferase isozymes (NAT1 and NAT2) expressed in Salmonella typhimurium.
Wild D; Feser W; Michel S; Lord HL; Josephy PD
Carcinogenesis; 1995 Mar; 16(3):643-8. PubMed ID: 7697826
[TBL] [Abstract][Full Text] [Related]
27. Differences in β-naphthylamine metabolism and toxicity in Chinese hamster ovary cell lines transfected with human CYP1A2 and NAT2*4, NAT2*5B or NAT2*7B N-acetyltransferase 2 haplotypes.
Habil MR; Salazar-González RA; Doll MA; Hein DW
Arch Toxicol; 2022 Nov; 96(11):2999-3012. PubMed ID: 36040704
[TBL] [Abstract][Full Text] [Related]
28. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.
Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461
[TBL] [Abstract][Full Text] [Related]
29. Rodent models of the human acetylation polymorphism: comparisons of recombinant acetyltransferases.
Hein DW; Doll MA; Fretland AJ; Gray K; Deitz AC; Feng Y; Jiang W; Rustan TD; Satran SL; Wilkie TR
Mutat Res; 1997 May; 376(1-2):101-6. PubMed ID: 9202744
[TBL] [Abstract][Full Text] [Related]
30. Arylamine N-acetyltransferase acetylation polymorphisms: paradigm for pharmacogenomic-guided therapy- a focused review.
Hein DW; Millner LM
Expert Opin Drug Metab Toxicol; 2021 Jan; 17(1):9-21. PubMed ID: 33094670
[TBL] [Abstract][Full Text] [Related]
31. N-Acetyltransferase-2 (NAT2) gene polymorphisms and enzyme activity in Serbs: unprecedented high prevalence of rapid acetylators in a White population.
Djordjevic N; Carrillo JA; Ueda N; Gervasini G; Fukasawa T; Suda A; Jankovic S; Aklillu E
J Clin Pharmacol; 2011 Jul; 51(7):994-1003. PubMed ID: 20801937
[TBL] [Abstract][Full Text] [Related]
32. Para-phenylenediamine and allergic sensitization: risk modification by N-acetyltransferase 1 and 2 genotypes.
Blömeke B; Brans R; Coenraads PJ; Dickel H; Bruckner T; Hein DW; Heesen M; Merk HF; Kawakubo Y
Br J Dermatol; 2009 Nov; 161(5):1130-5. PubMed ID: 19663877
[TBL] [Abstract][Full Text] [Related]
33. Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1,GSTT1, NAT1 and NAT2.
Godschalk RW; Dallinga JW; Wikman H; Risch A; Kleinjans JC; Bartsch H; Van Schooten FJ
Pharmacogenetics; 2001 Jul; 11(5):389-98. PubMed ID: 11470992
[TBL] [Abstract][Full Text] [Related]
34. Tissue distribution of N-acetyltransferase 1 and 2 catalyzing the N-acetylation of 4-aminobiphenyl and O-acetylation of N-hydroxy-4-aminobiphenyl in the congenic rapid and slow acetylator Syrian hamster.
Hein DW; Doll MA; Nerland DE; Fretland AJ
Mol Carcinog; 2006 Apr; 45(4):230-8. PubMed ID: 16482518
[TBL] [Abstract][Full Text] [Related]
35. Acetylator genotype-dependent metabolic activation of carcinogenic N-hydroxyarylamines by S-acetyl coenzyme A-dependent enzymes of inbred hamster tissue cytosols: relationship to arylamine N-acetyltransferase.
Hein DW; Flammang TJ; Kirlin WG; Trinidad A; Ogolla F
Carcinogenesis; 1987 Dec; 8(12):1767-74. PubMed ID: 3677303
[TBL] [Abstract][Full Text] [Related]
36. Higher frequency of aberrant crypt foci in rapid than slow acetylator inbred rats administered the colon carcinogen 3,2'-dimethyl-4-aminobiphenyl.
Feng Y; Fretland AJ; Rustan TD; Jiang W; Becker WK; Hein DW
Toxicol Appl Pharmacol; 1997 Nov; 147(1):56-62. PubMed ID: 9356307
[TBL] [Abstract][Full Text] [Related]
37. 2-Amino-3,8-dimethylimidazo-[4,5-f]quinoxaline-induced DNA adduct formation and mutagenesis in DNA repair-deficient Chinese hamster ovary cells expressing human cytochrome P4501A1 and rapid or slow acetylator N-acetyltransferase 2.
Bendaly J; Zhao S; Neale JR; Metry KJ; Doll MA; States JC; Pierce WM; Hein DW
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1503-9. PubMed ID: 17627018
[TBL] [Abstract][Full Text] [Related]
38. Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines.
Liu L; Wagner CR; Hanna PE
Chem Res Toxicol; 2009 Dec; 22(12):1962-74. PubMed ID: 19842618
[TBL] [Abstract][Full Text] [Related]
39. N-acetyltransferase 2 polymorphism and acetylation profiles in Buginese ethnics of Indonesia.
Yuliwulandari R; Susilowati RW; Razari I; Viyati K; Umniyati H; Prayuni K
Ann Hum Genet; 2019 Nov; 83(6):465-471. PubMed ID: 31332782
[TBL] [Abstract][Full Text] [Related]
40. Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2.
Walraven JM; Doll MA; Hein DW
J Pharmacol Exp Ther; 2006 Oct; 319(1):369-75. PubMed ID: 16829624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
